Nathalie Dubois-Stringfellow

Insider Reports History

Entity
Individual
Location
C/O Sangamo Therapeutics, Inc., 7000 Marina Boulevard, Brisbane, CA
Signature
/s/ Ron A. Metzger, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nathalie Dubois-Stringfellow:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SANGAMO THERAPEUTICS, INC SVP-CHIEF DEVELOPMENT OFFICER Common Stock 845K $726K $0.86 Aug 25, 2024 Direct

Insider Reports Filed by Nathalie Dubois-Stringfellow

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SGMO SANGAMO THERAPEUTICS, INC Aug 24, 2024 2 -$2.83K 4 Aug 27, 2024 SVP-CHIEF DEVELOPMENT OFFICER
SGMO SANGAMO THERAPEUTICS, INC May 24, 2024 2 -$1.98K 4 May 29, 2024 SVP-CHIEF DEVELOPMENT OFFICER
SGMO SANGAMO THERAPEUTICS, INC Feb 24, 2024 2 -$11.8K 4 Feb 27, 2024 SVP-CHIEF DEVELOPMENT OFFICER
SGMO SANGAMO THERAPEUTICS, INC Jan 22, 2024 1 $0 4 Jan 24, 2024 SVP-CHIEF DEVELOPMENT OFFICER
SGMO SANGAMO THERAPEUTICS, INC Nov 25, 2023 1 -$559 4 Nov 28, 2023 SVP-Chief Development Officer
SGMO SANGAMO THERAPEUTICS, INC Aug 25, 2023 1 -$1.13K 4 Aug 29, 2023 SVP-Chief Development Officer
SGMO SANGAMO THERAPEUTICS, INC May 25, 2023 1 -$1.94K 4 May 30, 2023 SVP-Chief Development Officer
SGMO SANGAMO THERAPEUTICS, INC Feb 24, 2023 3 -$26.2K 4 Mar 6, 2023 SVP-Chief Development Officer
SGMO SANGAMO THERAPEUTICS, INC Sep 9, 2022 0 $0 3 Sep 19, 2022 SVP-Chief Development Officer